Tianqiang Song

Distinct clinical and prognostic implication of IDH1/2 mutation and other most frequent mutations in large duct and small duct subtypes of intrahepatic cholangiocarcinoma

Bingqi Ma, Huijuan Meng, Ye Tian et al. · BMC Cancer · 2020 · 92 citations · Full text

Medicine, Oncology, Pathology +17

Adjuvant interferon for early or late recurrence of hepatocellular carcinoma and mortality from hepatocellular carcinoma following curative treatment: A meta-analysis with comparison of different types of hepatitis

Wei Zhang, Tianqiang Song, Ti Zhang et al. · Molecular and Clinical Oncology · 2014 · 40 citations · Full text

Medicine, Oncology, Surgery +17

Adjuvant sorafenib reduced mortality and prolonged overall survival and post-recurrence survival in hepatocellular carcinoma patients after curative resection: A single-center experience

Wei Zhang, Gang Zhao, Kai Wei et al. · BioScience Trends · 2014 · 33 citations · Full text

Medicine, Oncology, Surgery +16

Apatinib as first-line treatment in patients with advanced hepatocellular carcinoma: a phase II clinical trial

Zhenyu Hou, Keyun Zhu, Xuejiao Yang et al. · Annals of Translational Medicine · 2020 · 31 citations · Full text

Medicine, Oncology, Pharmacology +17

Facile Fabrication of Reduction-Responsive Supramolecular Nanoassemblies for Co-delivery of Doxorubicin and Sorafenib toward Hepatoma Cells

Qingqing Xiong, Mangmang Cui, Yu Ge et al. · Frontiers in Pharmacology · 2018 · 24 citations · Full text

Pharmacy, Oncology, Pharmaceutics +17